Posted by rvanson on October 21, 2007, at 1:04:04
In reply to Re: Agomelatine for Major Depressive Disorder?, posted by jrbecker76 on October 18, 2007, at 15:58:11
There is a study comparing Agomelatine to Paxil vs. placebo near me, but I can't take the chance of ending up in the Paxil-hell loop again and I'd know if if it was a placebo, as that non effect has never happened to me, ever, as I am side-effect sensitive to any real medications.
Sure sounds like a novel AD/anti-anxiety med so I hope it makes it to the shelves if it passes muster.
> Agomelatine is still active in Phase III in both the U.S. and Europe. In the U.S., Novartis is planning on submitting this for FDA review in mid-to-late 2008. Servier Labs has been hush hush about their plans to re-submit in Europe, but alluded earlier that it would be somewhat of a short timetable in doing so.<<<<<
poster:rvanson
thread:789701
URL: http://www.dr-bob.org/babble/20071019/msgs/790434.html